Related Experiment Video
Updated: May 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity
Ying He1, Guili Lian, Shuyong Lin
1State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Fujian, China.
Abstract:
MDM2 plays a crucial role in negatively regulating the functions of tumor suppressor p53. Here we show that MDM2 can inhibit Axin-stimulated p53-dependent apoptosis by suppressing p53 phosphorylation at Ser 46 and apoptosis-related p53 transactivational activity. Interestingly, the ubiquitin E3 ligase activity of MDM2 is not required for this inhibitory effect. Mechanically, either wildtype MDM2 or its E3-dead mutant, disrupts the Axin-based HIPK2/p53 complex formation by blocking the binding of p53 and HIPK2 to Axin. MDM2Δp53, a deletion mutant that lacks p53 binding domain fails to exert the inhibitory effect, demonstrating that the interaction of MDM2 and p53, but not its E3 ligase activity toward p53 plays key role in suppressing Axin-stimulated p53 activation. Our results thus have revealed a novel aspect of the mechanism by which MDM2 regulates p53 activities.
Insights
MDM2 inhibits tumor suppressor p53 activation by disrupting the HIPK2/p53 complex with Axin. This interaction, not MDM2
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- MDM2 negatively regulates tumor suppressor p53.
- p53 is crucial for apoptosis and cell cycle arrest.
- Axin and HIPK2 are involved in p53 activation.
Purpose of the Study:
- To investigate the mechanism by which MDM2 inhibits Axin-stimulated p53 activation.
- To determine the role of MDM2's E3 ligase activity in this inhibition.
Main Methods:
- Western blotting to detect protein interactions and phosphorylation.
- Co-immunoprecipitation assays to study complex formation.
- Analysis of p53 transactivational activity.
Main Results:
- MDM2 inhibits Axin-stimulated p53-dependent apoptosis by suppressing p53 phosphorylation at Ser 46.
- MDM2's ubiquitin E3 ligase activity is not required for this inhibition.
- MDM2 disrupts the Axin-based HIPK2/p53 complex by blocking p53 and HIPK2 binding to Axin.
- MDM2 interaction with p53, not its E3 ligase activity, is key to suppressing p53 activation.
Conclusions:
- MDM2 has a novel mechanism for regulating p53 activity.
- MDM2 interaction with p53 suppresses Axin-stimulated p53 activation independently of its E3 ligase function.
- This finding provides new insights into cancer therapy strategies targeting the p53 pathway.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The JAK-STAT Signaling Pathway
Negative Regulator Molecules

